KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Current Taxes (2019 - 2020)

Boston Scientific's Current Taxes history spans 7 years, with the latest figure at $174.0 million for Q3 2025.

  • For Q3 2025, Current Taxes fell 39.16% year-over-year to $174.0 million; the TTM value through Sep 2025 reached $174.0 million, down 39.16%, while the annual FY2024 figure was $268.0 million, 21.82% up from the prior year.
  • Current Taxes for Q3 2025 was $174.0 million at Boston Scientific, up from $173.0 million in the prior quarter.
  • Across five years, Current Taxes topped out at $459.0 million in Q1 2022 and bottomed at $151.0 million in Q1 2021.
  • The 5-year median for Current Taxes is $234.0 million (2022), against an average of $259.8 million.
  • The largest annual shift saw Current Taxes soared 203.97% in 2022 before it crashed 39.16% in 2025.
  • A 5-year view of Current Taxes shows it stood at $209.0 million in 2021, then increased by 11.0% to $232.0 million in 2022, then fell by 5.17% to $220.0 million in 2023, then rose by 21.82% to $268.0 million in 2024, then tumbled by 35.07% to $174.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Current Taxes are $174.0 million (Q3 2025), $173.0 million (Q2 2025), and $315.0 million (Q1 2025).